Jan 23, 2019 - A slowdown in Europe and the ongoing trade conflicts have been cited as the major reasons for the IMF's projection cuts.
Jan 23, 2019 - Results from a few clinical trials reading out in 2019 could make it a year to remember.
Jan 22, 2019 - Companies In The News Are:
Jan 18, 2019 - Pfizer's (PFE) tafamidis application gets FDA's priority review. Regulatory updates for Roche's (RHHBY) and Bristol-Myers'(BMY) cancer combination drugs in focus.
Jan 18, 2019 - Lilly (LLY) possesses solid growth attributes, which could help it handily outperform the market.
Jan 16, 2019 - Intrexon (XON) partners with Next Green Wave Holdings to utilize Intrexon's Botticelli next-generation plant propagation platform.
Jan 15, 2019 - Bristol-Myers (BMY) gets EU approval for the immuno-oncology combination of Opdivo and low-dose Yervoy for the first-line treatment of patients with intermediate- and poor-risk advanced RCC.
Jan 13, 2019 - The biopharma delivered the goods with its drug pipeline, scored marketing approval for its lead drug candidate, and agreed to be acquired for $8 billion.
Jan 11, 2019 - Lilly (LLY) is spending $8 billion to buy small cancer biotech Loxo Oncology. Big Pharma CEOs hint at spur in M&A activity in 2019.
Jan 11, 2019 - Here we present four therapeutic areas whose pipeline developments are expected to garner a lot of interest in 2019.